Werner Cautreels
Ph.D. President and CEO
Selecta Biosciences
Australia
Biography
Prior to joining Selecta Biosciences, Inc. in 2010, Dr. Cautreels was Chief Executive Officer of Solvay Pharmaceuticals, the pharmaceuticals division of the Solvay Group, in Brussels, Belgium, from 2005 until Solvay Pharmaceuticals was acquired by Abbott Laboratories in 2010. Before becoming the CEO of Solvay Pharmaceuticals, Dr. Cautreels was its Global Head of R&D.
Research Interest
Molecular Biology and Molecular Genetics
